FDA escalates recall of blood pressure drug amid carcinogen concerns—yet another failure in Big Pharma’s toxic empire

FDA escalates recall of blood pressure drug amid carcinogen concerns—yet another failure in Big Pharma’s toxic empire

The FDA upgraded its recall of metoprolol succinate, a widely prescribed blood pressure drug, from Class III to Class II due to potential carcinogenic risks and dissolution failures, indicating a higher likelihood of adverse health effects. The recall highlig…

  • The FDA upgraded its recall of metoprolol succinate, a widely prescribed blood pressure drug, from Class III to Class II due to potential carcinogenic risks and dissolution failures, indicati… [+6495 chars]

Related Posts

About FHMnews

What is FHMnews?

FHMnews is the result of a rebellion that transcended frustration. Look around you. As PK puts it, the people in this circle think one thing, say another, and do another. We shook up all three, confined within one circle, and decided to write as they think and speak. News, views, and everything beyond.

FHMnews is the country's first "new age" English news website. It's modern in its language, attitude, and news standards. It features selected news stories from the day, but with 360-degree coverage. It offers a complete report and analysis of each story, along with additional features like quizzes, polls, memes, and videos.

FHMnews Ltd.

E-43, Phase 8
Sahibzada Ajit Singh Nagar,
Punjab, 160071

Get In Touch With Us

© Copyright FHMnews
FDA escalates recall of blood pressure drug amid carcinogen concerns—yet another failure in Big Pharma’s toxic empire - FHMnews